x
ServiziMenu principaleHome

Editorial board

Chairmen

  • James O. Armitage, University of Nebraska Medical Center, Omaha, US
  • Manuela Bergmann, Schwabing Clinic, Munich, DE
  • Franco Cavalli, European School of Oncology (ESO) and Oncology Institute of Southern Switzerland, Bellinzona, CH
  • Stephan Stilgenbauer, Ulm University Hospital, DE

Scientific Directors

  • Elias Campo, University of Barcelona, Barcelona, ES
  • Bertrand Coiffier, Centre Hospitalier Lyon Sud, Pierre Bénite, FR
  • Andreas Engert, University Clinic Cologne, Cologne, DE
  • Massimo Federico, University of Modena and Reggio Emilia, Modena, IT
  • Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Novara, IT
  • Randy Gascoyne, B.C. Cancer Agency, Vancouver, CA
  • Mary Gospodarowicz, Princess Margaret Hospital - University of Toronto, Toronto, CA
  • Anton Hagenbeek, University of Amsterdam - Academic Medical Centre, Amsterdam, NL
  • T. Andrew Lister, St. Bartholomew's Hospital, London, UK
  • Julie M. Vose, University of Nebraska Medical Center, Omaha, US
  • Emanuele Zucca, Oncology Institute of Southern Switzerland, Bellinzona, CH

Lecturers: Seminar 1

Lecturers to be confirmed

Lecturers: Module 1

  • Francesco Bertoni, IOSI - Oncology Institute of Southern Switzerland, Bellinzona, CH
  • George A. Calin, The RNA Interference and Non-codingRNA Center at MD Anderson Cancer Center, Houston, TX, US
  • Pedro Farinha, Centro Hospitalar Lisboa Central & Faculdade de Ciências Médicas da Universidade Nova de Lisboa, Lisbon, PT
  • Ralf Küppers, University of Duisburg-Essen, Essen, DE
  • Laura Pasqualucci, Institute for Cancer Genetics and Dpt of Pathology and Cell Biology, Columbia University, New York, NY, US
  • Daniel Mertens, University Hospital Ulm, Ulm, DE
  • Ryan Morin, Simon Fraser University and Scientist, British Columbia Cancer Agency, CA
  • Stefano A. Pileri, Bologna University School of Medicine, Bologna, IT
  • Diego Serraino, National Cancer Institute - Centro di Riferimento Oncologico, Aviano, IT
  • Mariagrazia Uguccioni, Institute for Research in Biomedicine, Bellinzona, CH

Lecturers Module 2

  • Berthe M.P. Aleman, The Netherlands Cancer Institute, Amsterdam, NL
  • James O. Armitage, University of Nebraska Medical Center, Omaha, NE,  US
  • Sally Barrington, PET Centre at St Thomas', Kings College London, London, UK
  • Nikolai C. Brun, Genmab A/S, Copenhagen, DK
  • Bruce D. Cheson, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, D.C., US
  • Daphne de Jong, VU University Medical Center, Amsterdam, NL
  • Kieron Dunleavy, National Cancer Institute, Bethesda, MD, US
  • Jonathan W. Friedberg, University of Rochester, James P. Wilmot Cancer Center, Rochester, NY, USA
  • Gerhard Held, Saarland University, Homburg, DE
  • Peter Möller, University Hospital Ulm, Ulm, DE
  • Silvia Montoto, Barts Cancer Institute, London, UK
  • Jakob Passweg, University Hospital Basle, Basle, DE
  • Dietrich Rothenbacher, Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, DE
  • Richard F. Schlenk, University Hospital Ulm, Ulm, DE
  • Alessandro Rambaldi, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, IT
  • Laurie H. Sehn, Centre for Lymphoid Cancer, BC Cancer Agency and the University of British Columbia, Vancouver, BC, CA
  • Margaret A. Shipp, Dana Farber Cancer Institute, Harvard Medical School, Boston, US
  • Anastasios Stathis, Clinical Research Unit, Oncology Institute of Southern Switzerland, Bellinzona, CH
  • Julie M. Vose, University of Nebraska Medical Center, Nebraska, US
  • Emanuele Zucca, Oncology Institute of Southern Switzerland, Bellinzona, CH

Lecturers: Seminar 2

Lecturers to be confirmed

Lecturers: Module 3

  • James O. Armitage, University of Nebraska Medical Centre, Hematology-Oncology Section, Nebraska, US
  • Manuela Bergmann, Comprehensive Cancer Center Ulm, Ulm, DE
  • Franco Cavalli, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
  • Joseph M. Connors, British Columbia Cancer Agency, Vancouver, CA
  • Andrew Davies, University of Southampton School of Medicine, Somers Cancer Research Building, Southampton General Hospital, Southampton, UK
  • Angela Dispenzieri, Mayo Clinic, Division of Hematology, Department of Internal Medicine, Rochester, Minnesota, US
  • Martin Dreyling, Ludwig Maximilians-University München, University Hospital Großhadern, Dept. of Medicine, München, DE
  • Kieron Dunleavy, Center for Cancer Research, National Cancer Institute, Bethesda, MD, US
  • Andrés Ferreri, San Raffaele Scientific Institute, Milan, IT
  • Francesco Forconi, University of Southampton School of Medicine,  Somers Cancer Research Building, Southampton General Hospital, Southampton, UK 
  • Paolo Ghia, Università Vita - Salute San Raffaele, Medical School, Milano, IT
  • Michele Ghilemini, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
  • Christian Gisselbrecht, Hospital Saint Louis University Paris 7, Hemato-Oncology Department, Paris, FR
  • T. Andrew Lister, Barts Cancer Institute - a Cancer Research UK Centre of Excellence Queen Mary, University of London, London, UK
  • Werner Kempf, Medical School University of Zürich, Switzerland
  • Eva Kimby, Karolinska University Hospital, Hematology Center, M 54, Stockholm, SE
  • Ralf Kueppers, University of Duisburg-Essen, Essen, DE
  • Ian Magrath, International Network for Cancer Treatment and Research, Brussels, BE
  • Emili Montserrat, Hospital Clinic, University of Barcelona, Barcelona, ES
  • Antonio Palumbo, University of Turin, Dept. of Onco-Hematology, Turin, IT
  • Davide Rossi, Amedeo Avogadro University of Eastern Piedmont, Department of Haematology, Novara, IT
    Gilles Salles, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Department of Hematology, Lyon, FR
  • Stephan Stilgenbauer, University of Ulm, Department  of Internal Medicine 3, Haematology and Oncology, Ulm, DE
  • Catherine Thieblemont, Hôpital Saint-Louis, Paris, FR

Lecturers: Module 4

  • Emilio Berti, University of Milan-Bicocca, Milan, IT
  • Bertrand Coiffier, Centre Hospitalier Lyon Sud, Pierre Bénite, FR
  • Claire Dearden, The Royal Marsden NHS Foundation Trust, Haemato-Oncology Unit & HMDS, London, UK
  • Dennis Eichenauer, University Clinic Cologne, Cologne, DE
  • Andrew Evens, Tufts University School of Medicine, Tufts Medical Center, Division of Hematology/Oncology, Boston, MA, US
  • Massimo Federico, Massimo Federico, University of Modena  and Reggio Emilia, Modena, IT
  • Andrés Ferreri, San Raffaele Scientific Institute, Milan, IT
  • Andrea Gallamini, S. Croce and Carle Hospital, Cuneo, IT
  • Won Seog Kim, Samsung Medical Center, Division of Hematology-Oncology, Seoul, KOR
  • Stefano Luminari, University of Modena and Reggio Emilia, Modena Oncology Centre, Dpt of Diagnostic, Clinical and Public Health Medicine, Modena, IT
  • Dror Meirow, Sheba Medical Center, Clinical Center for Fertility Preservation and the Fertility Preservation Research Laboratory aTel-Hashomer, Israel
  • Monika Metzger, St. Jude Children's Research Hospital, Dept. of Oncology,  Leukemia / Lymphoma Division, Memphis, TN, US
  • Fedro Peccatori, European Institute of Oncology, Fertility & Procreation Unit, Division of Gynecologic Oncology, Milan, IT
  • Ruth Pettengell, St George’s Hospital Medical School, Dept. of Haematology and Oncology, London, UK 
  • Stefano A. Pileri, Bologna University School of Medicine, Haematopathology Unit, Bologna, IT
  • Zbigniew Rudzki, Heartlands Hospital,  Department of Cellular Pathology, Birmingham, UK   
  • Stefano Sacchi, University of Modena and Reggio Emilia, Department of Oncology and Hematology, Modena, IT
  • John Sandlund, St. Jude Children's Research Hospital, Dept. of Oncology,  Leukemia / Lymphoma Division, Memphis, TN, US 
  • Kerry Savage, British Columbia Cancer Agency, Vancouver, CA
  • Bastian von Tresckow, University Clinic Cologne, Cologne, DE

Conceptual Development and Organisation

  • Uta Schmidt-Strassburger, Ulm, DE
  • Marcel Sailer, Soon Systems GmbH, Ulm, DE
  • Chatrina Melcher, ESO, Bellinzona, CH
  • Dolores Knupfer, ESO, Bellinzona, CH

Follow us